Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.
Sigurdsson ST, Paulson OB, Høj Nielsen A, Strandgaard S.
J Cereb Blood Flow Metab. 2014 Mar;34(3):467-71. doi: 10.1038/jcbfm.2013.219. Epub 2013 Dec 11.
Similar articles
Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study.
Boesby L, Elung-Jensen T, Strandgaard S, Kamper AL.
PLoS One. 2013 May 21;8(5):e64549. doi: 10.1371/journal.pone.0064549. Print 2013.
[Secondary prevention of stroke with effective antihypertensive treatment].
Boye Knudsen S, Strandgaard S, Paulson OB.
Ugeskr Laeger. 2013 Apr 8;175(15):1024-8. Review. Danish.
Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trial.
Frimodt-Møller M, Kamper AL, Strandgaard S, Kreiner S, Nielsen AH.
PLoS One. 2012;7(7):e41757. doi: 10.1371/journal.pone.0041757. Epub 2012 Jul 31.
Ambulatory arterial stiffness index in chronic kidney disease stage 2-5. Reproducibility and relationship with pulse wave parameters and kidney function.
Boesby L, Thijs L, Elung-Jensen T, Strandgaard S, Kamper AL.
Scand J Clin Lab Invest. 2012 Jul;72(4):304-12. doi: 10.3109/00365513.2012.682164. Epub 2012 May 6.
Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease.
Orskov B, Christensen KB, Feldt-Rasmussen B, Strandgaard S.
Kidney Int. 2012 May;81(9):919-24. doi: 10.1038/ki.2011.459. Epub 2012 Feb 1.
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.
Boesby L, Elung-Jensen T, Klausen TW, Strandgaard S, Kamper AL.
PLoS One. 2011;6(11):e26904. doi: 10.1371/journal.pone.0026904. Epub 2011 Nov 4.
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease.
Orskov B, Sørensen VR, Feldt-Rasmussen B, Strandgaard S.
Nephrol Dial Transplant. 2012 Apr;27(4):1607-13. doi: 10.1093/ndt/gfr467. Epub 2011 Aug 26.
Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.
Orskov B, Rømming Sørensen V, Feldt-Rasmussen B, Strandgaard S.
Clin J Am Soc Nephrol. 2010 Nov;5(11):2034-9. doi: 10.2215/CJN.01460210. Epub 2010 Jul 29.
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
Frimodt-Møller M, Høj Nielsen A, Strandgaard S, Kamper AL.
Nephrol Dial Transplant. 2010 Mar;25(3):842-7. doi: 10.1093/ndt/gfp547. Epub 2009 Nov 9.
Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease.
Orskov B, Borresen ML, Feldt-Rasmussen B, Østergaard O, Laursen I, Strandgaard S.
Am J Nephrol. 2010;31(1):53-7. doi: 10.1159/000256657. Epub 2009 Nov 4.
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Oprisiu-Fournier R, Faure S, Mazouz H, Boutitie F, Serot JM, Achard JM, Godefroy O, Hanon O, Temmar M, Albu A, Strandgaard S, Wang J, Black SE, Fournier A.
Expert Rev Neurother. 2009 Sep;9(9):1289-305. doi: 10.1586/ern.09.88. Review.
[Hypertension and renal disease].
Kamper AL, Pedersen EB, Strandgaard S.
Ugeskr Laeger. 2009 Jun 15;171(25):2109-13. Danish.
[Hypertension and the brain].
Christensen H, Strandgaard S.
Ugeskr Laeger. 2009 Jun 8;171(24):2025-8. Danish.
Last Word on Point:Counterpoint: Sympathetic nervous activity does/does not influence cerebral blood flow.
Strandgaard S, Sigurdsson ST.
J Appl Physiol (1985). 2008 Oct;105(4):1375. doi: 10.1152/japplphysiol.91088.2008. No abstract available.
Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow. Counterpoint: Sympathetic nerve activity does not influence cerebral blood flow.
J Appl Physiol (1985). 2008 Oct;105(4):1366-7; discussion 1367-8. doi: 10.1152/japplphysiol.90597.2008a. No abstract available.
Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
Wang D, Strandgaard S, Iversen J, Wilcox CS.
Am J Physiol Regul Integr Comp Physiol. 2009 Feb;296(2):R195-200. doi: 10.1152/ajpregu.90506.2008. Epub 2008 Aug 6.
Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5.
Elung-Jensen T, Strandgaard S, Kamper AL.
Nephrol Dial Transplant. 2008 Sep;23(9):2873-8. doi: 10.1093/ndt/gfn126. Epub 2008 Mar 19.
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease.
Wang D, Strandgaard S, Borresen ML, Luo Z, Connors SG, Yan Q, Wilcox CS.
Am J Kidney Dis. 2008 Feb;51(2):184-91. doi: 10.1053/j.ajkd.2007.09.020.
Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease.
Frimodt-Møller M, Nielsen AH, Kamper AL, Strandgaard S.
Nephrol Dial Transplant. 2008 Feb;23(2):594-600. Epub 2007 Nov 7.
Filters: Manage Filters